Investigation of corrosion behaviour of magnesium alloy AM60B-F under pseudo-physiological conditions

被引:46
作者
Lévesque, J [1 ]
Dubé, D
Fiset, M
Mantovani, D
机构
[1] Univ Laval, Dept Min Met & Mat Engn, Quebec City, PQ G1K 7P4, Canada
[2] St Francis Assisi Hosp, Lab Biomat & Bioengn, Quebec City, PQ G1L 3L5, Canada
来源
THERMEC'2003, PTS 1-5 | 2003年 / 426-4卷
关键词
coronary stent; magnesium; magnesium alloys; AM60B; corrosion; degradable stent; test bench; static tests; dynamic tests;
D O I
10.4028/www.scientific.net/MSF.426-432.521
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
Endovascular stents have proven effective in treating coronary and peripheral arterial occlusions. All metallic materials currently used to make these devices are considered to be corrosion-resistant, and are therefore implanted on a long-term basis. Complications, however, have often been reported, such as restenosis and thrombosis. To reduce the risk of thrombus formation and restenosis, it would be useful to develop a new family of degradable stents. In fact, in most clinical cases, the occluded artery requires a stent only for a period of up to one year. Interesting candidate materials for manufacture of degradable stents include magnesium alloys, magnesium being an element that is essential to the organism and has a high electronegative potential. Success in using magnesium alloys for making endovascular devices is closely related to the properties of the selected alloy. Ideally, the alloy should degrade slowly, be ductile, be nontoxic, and corrode uniformly. Given these desired properties, we investigated the potential of magnesium alloys as degradable endovascular biomaterials. A test bench was designed and evaluated to reproduce the physiological conditions encountered in coronary arteries.
引用
收藏
页码:521 / 526
页数:6
相关论文
共 15 条
[1]  
[Anonymous], 2000, MAGNESIUM BIOL MED
[2]   ASSESSMENT OF WALL SHEAR-STRESS IN ARTERIES, APPLIED TO THE CORONARY CIRCULATION [J].
BENSON, TJ ;
NEREM, RM ;
PEDLEY, TJ .
CARDIOVASCULAR RESEARCH, 1980, 14 (10) :568-576
[3]  
BOFFETTA P, 1993, SCAND J WORK ENV HEA, V19, P67
[4]  
Datta A., 2002, U. S. Patent, Patent No. 6338739
[5]   A RANDOMIZED COMPARISON OF CORONARY-STENT PLACEMENT AND BALLOON ANGIOPLASTY IN THE TREATMENT OF CORONARY-ARTERY DISEASE [J].
FISCHMAN, DL ;
LEON, MB ;
BAIM, DS ;
SCHATZ, RA ;
SAVAGE, MP ;
PENN, I ;
DETRE, K ;
VELTRI, L ;
RICCI, D ;
NOBUYOSHI, M ;
CLEMAN, M ;
HEUSER, R ;
ALMOND, D ;
TEIRSTEIN, PS ;
FISH, RD ;
COLOMBO, A ;
BRINKER, J ;
MOSES, J ;
SHAKNOVICH, A ;
HIRSHFELD, J ;
BAILEY, S ;
ELLIS, S ;
RAKE, R ;
GOLDBERG, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (08) :496-501
[6]  
Fox M.R.S., 1988, Handbook on Toxicity of Inotganic Compounds, P345
[7]   Long-term patency of metallic stents in a 20-year-old saphenous vein coronary bypass graft [J].
Kussmaul, WG ;
Kempf, FC ;
Kershbaum, KL .
AMERICAN HEART JOURNAL, 1996, 131 (04) :836-839
[8]   Surface reaction of magnesium in Hank's solutions [J].
Kuwahara, H ;
Al-Abdullat, Y ;
Ohta, M ;
Tsutsumi, S ;
Ikeuchi, K ;
Mazaki, N ;
Aizawa, T .
MAGNESIUM ALLOYS 2000, 2000, 350-3 :349-358
[9]  
LEVESQUE J, 2002, S ADV MAT BIOM APPL, P191
[10]  
NIEMEYER M, 2001, 7 EUR C ADV MAT PROC